Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NVO | SCHW |
|---|---|---|
| Price | $38.34 | $99.56 |
| Change today | ▲ 0.43% | ▲ 0.06% |
| Market cap | $171.17B | $172.16B |
| Return, 3 months | -18.1% | +9.3% |
| Return, year to date | -21.0% | +0.6% |
| Return, 1 year | -31.6% | +9.2% |
| P/E (TTM) | 9.6 | 18.1 |
| P/B | 5.1 | 3.9 |
| P/E percentile vs own 5y | 4th | 20th |
| Dividend yield | 4.65% | 1.19% |
| Revenue growth (YoY, latest qtr) | +2.1% | +20.9% |
| Net profit growth (YoY) | -20.8% | +31.7% |
| Gross margin | 80.6% | – |
| Operating margin | 43.1% | – |
| Net margin | 35.3% | 37.4% |
| Return on equity | 59.8% | 22.4% |
| Analyst target vs. price | +13.9% | +25.3% |
| Analyst buy share | 0% | 82% |
| RSI (14) | 29 | 36 |
| 30-day volatility | 37.8% | 27.6% |
| Max drawdown, 1 year | -43.7% | -19.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.